T. Suedhoff
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in ⓘ
- Oncology 10
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 4
-
- Renal cell carcinoma treatment 4
- Prostate Cancer Treatment and Research 2
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Dieter Buchheidt (2 shared papers)Corinna Baust (1 shared paper)Heyko Skladny (1 shared paper)Rüediger Hehlmann (1 shared paper)Wolfgang Seifarth (1 shared paper)M. Baldus (1 shared paper)J. Ritter (1 shared paper)Thomas Gruenberger (4 shared papers)
In The Last Decade
T. Suedhoff
13 papers receiving 450 citations
Peers
Comparison fields: 5 of 48
- Hepatology 140
- Infectious Diseases 187
- Oncology 229
- Small Animals 45
- Epidemiology 195
Countries citing papers authored by T. Suedhoff
This map shows the geographic impact of T. Suedhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Suedhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Suedhoff more than expected).
Fields of papers citing papers by T. Suedhoff
This network shows the impact of papers produced by T. Suedhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Suedhoff. The network helps show where T. Suedhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Suedhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 174 | |
| 2 | 2001 | 117 | |
| 3 | 2012 | 80 | |
| 4 | 2011 | 25 | |
| 5 | C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation. | 2007 | 16 |
| 6 | 2014 | 12 | |
| 7 | 2012 | 12 | |
| 8 | 2006 | 7 | |
| 9 | 2011 | 6 | |
| 10 | 1998 | 5 | |
| 11 | 2013 | 5 | |
| 12 | 1998 | 4 | |
| 13 | 2011 | 1 | |
| 14 | 2006 | 0 |
About T. Suedhoff
T. Suedhoff is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Hematology and Cancer Research, having authored 14 papers that have together received 464 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Renal cell carcinoma treatment (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Prostate Cancer Treatment and Research (2 papers), Antifungal resistance and susceptibility (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Hepatology (140 citations), Infectious Diseases (187 citations), Oncology (229 citations), Small Animals (45 citations) and Epidemiology (195 citations). T. Suedhoff has collaborated with scholars based in Germany and Austria. Frequent co-authors include Dieter Buchheidt, Corinna Baust, Heyko Skladny, Rüediger Hehlmann, Wolfgang Seifarth, M. Baldus, J. Ritter, Thomas Gruenberger, Gunnar Folprecht and Wolf O. Bechstein. Their work appears in journals such as Journal of Clinical Oncology, Clinical Infectious Diseases, Cancer Microenvironment, Medical Oncology and Biomarker Insights.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.